Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid crawled date : 2021 - 02 - 02 save search
CVS Health to Administer COVID-19 Vaccines at 27 Pharmacy Locations in New Jersey as Part of Multi-State Activation
Published: 2021-02-02 (Crawled : 19:07) - prnewswire.com
CVS | $69.75 1.49% 0.13% 7.8M
|
Retail Trade
|
| O: -0.13%
H: 2.69%
C: 2.09%
covid vaccine at-527
CVS Health to Administer COVID-19 Vaccines at 18 Pharmacy Locations in Massachusetts as Part of Multi-State Activation
Published: 2021-02-02 (Crawled : 19:07) - prnewswire.com
CVS | $69.75 1.49% 0.13% 7.8M
|
Retail Trade
|
| O: -0.13%
H: 2.69%
C: 2.09%
covid vaccine
CVS Health to Administer COVID-19 Vaccines at 70 Pharmacy Locations in Texas as Part of Multi-State Activation
Published: 2021-02-02 (Crawled : 19:07) - prnewswire.com
CVS | $69.75 1.49% 0.13% 7.8M
|
Retail Trade
|
| O: -0.13%
H: 2.69%
C: 2.09%
covid vaccine
CVS Health to Administer COVID-19 Vaccines at 4 Pharmacy Locations in Rhode Island as Part of Multi-State Activation
Published: 2021-02-02 (Crawled : 19:07) - prnewswire.com
CVS | $69.75 1.49% 0.13% 7.8M
|
Retail Trade
|
| O: -0.13%
H: 2.69%
C: 2.09%
covid vaccine
CVS Health to Administer COVID-19 Vaccines at 32 Pharmacy Locations in New York as Part of Multi-State Activation
Published: 2021-02-02 (Crawled : 19:07) - prnewswire.com
CVS | $69.75 1.49% 0.13% 7.8M
|
Retail Trade
|
| O: -0.13%
H: 2.69%
C: 2.09%
covid vaccine
CVS Health to Administer COVID-19 Vaccines at 28 Pharmacy Locations in Virginia as Part of Multi-State Activation
Published: 2021-02-02 (Crawled : 19:07) - prnewswire.com
CVS | $69.75 1.49% 0.13% 7.8M
|
Retail Trade
|
| O: -0.13%
H: 2.69%
C: 2.09%
covid vaccine
Edesa Biotech Receives C$14 million for COVID-19 Study
Published: 2021-02-02 (Crawled : 19:00) - biospace.com/
EDSA | $4.47 2.52% 2.46% 2.4K
|
Health Technology
|
| O: -0.32%
H: 31.88%
C: -2.91%
covid biotech covid-19
CVS Health Expands Community Access to COVID-19 Vaccines
Published: 2021-02-02 (Crawled : 18:07) - prnewswire.com
CVS | $69.75 1.49% 0.13% 7.8M
|
Retail Trade
|
| O: 0.34%
H: 1.32%
C: 0.18%
covid vaccine covid-19 expansion health
Novavax Announces Memorandum of Understanding to Produce COVID-19 Vaccine Made in Canada
Published: 2021-02-02 (Crawled : 18:00) - globenewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 0.44%
H: 0.86%
C: -1.88%
covid vaccine covid-19
Aeterna Zentaris Announces Evaluation and Potential Development of an Oral Prophylactic Bacterial Vaccine Against COVID-19 Through Exclusive Option Agreement with Julius-Maximilians-University Wuerzburg
Published: 2021-02-02 (Crawled : 13:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: 41.43%
H: 20.2%
C: 1.01%
covid vaccine potential
Tiziana Reports Positive Data from the Clinical Study of Nasal Administration with Foralumab, its proprietary fully human anti-CD3 monoclonal antibody, in COVID-19 Patients in Brazil
Published: 2021-02-02 (Crawled : 07:03) - globenewswire.com
TLSA | News | $0.6698 4.66% 4.45% 600K
|
Health Technology
|
| O: 30.37%
H: 0.2%
C: -8.84%
covid positive antibody brazil foralumab
Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science
Published: 2021-02-02 (Crawled : 01:00) - globenewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 0.44%
H: 0.86%
C: -1.88%
covid vaccine covid-19
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.